Verrica Announces Torii Amendment To Fund YCANTH Warts Phase 3 Trial
15 May 2024 //
GLOBENEWSWIRE
Torii Announces Positive Results from a Confirmatory Phase 3 Trial of TO-208
15 Dec 2023 //
GLOBENEWSWIRE
Verrica Pharma Starts PIII Trial of VP-102 for Molluscum Contagiosum
01 Aug 2022 //
GLOBENEWSWIRE
Verrica Announces Exclusive Licensing Agreement With Torii Pharmaceutical
17 Mar 2021 //
GLOBENEWSWIRE
Verrica Announces Option Agreement with Torii Pharma to Develop VP-102
05 Aug 2020 //
GLOBENEWSWIRE
Akebia Announces Collaboration Partner`s Submission of sNDA for Use of Riona®
18 May 2020 //
PRNEWSWIRE